KPV
Also known as: KPV tripeptide, alpha-MSH fragment
animal onlyNot FDA approvedResearch only
Mechanism of Action
KPV is a catalog-expanded peptide entry in ProtoComp's source-backed compound corpus. It is included for search, calculator math, stack awareness, and future research curation based on expand compound catalog, local_seed, seed corpus peptides. Published dosing, cycle length, and clinical-use claims are intentionally left null until compound-specific evidence is reviewed.
Published Dose Range
Low10 mg/day
Typical10-20 mg/day
High20 mg/day
Experimental. Animal studies used 1-5 mg/kg.
Published Cycle Range
No published cycle data available.
Administration
Routesoral, topical, subcutaneous
FrequencyDaily
Safety Profile
Pregnancy / breastfeeding
No data — consult clinician
Common Misconceptions
- NF-κB inhibition mechanism — anti-inflammatory, not hormonal
Next Steps
Sign in to calculate your dose, add this compound to your stack, and check for interactions with your current cabinet.